FROM PUBLIC EVENTS · 2026-11-15

Current stage

  1. Discovery · preclinical
  2. Early clinical · first deals
  3. Late clinical · capacity
  4. Commercial · sales
  1. Global approvals · expansion
  2. M&A · integration
  3. Pipeline reshaping

Early clinical · first deals Has begun supplying its own culture media to customers and started contract media manufacturing.

  • Started contract media manufacturing at its Songdo plant. Source

Roles often seen at this stageManufacturing & MSAT · Research & development · BD & licensing

Companies at the same stage and their people flow →

← Company library
Korea / Company briefSources checked 2026-11-15

Amicogen

A maker of enzymes and bioprocessing materials such as cell-culture media and resins for biologics, which has started contract media manufacturing at its Songdo plant.

Cell culture media

Marketed

Cell-culture media for biologics production, now supplied to Korean drug makers.

Protein purification resin

Stage unconfirmed

Resin for antibody purification.

Announced

Started contract manufacturing of customers' own media formulations at its Songdo media plant.

Official role guide

Amicogen careers

Current availability unconfirmed

Observed 2026-11-15

Work
Unconfirmed — The official careers page could not be confirmed.
Experience & requirements
Unconfirmed — The official careers page could not be confirmed.

Information from a role guide does not establish a current vacancy.

Sources & coverage 2

A brief based on selected official material, not an exhaustive product or vacancy list.

  1. 아미코젠, 해외서 만들던 '전용 배지' 송도로…바이오 원부자재 CMO 시동 ↗파이낸셜뉴스 · Published 2026-10-01 · Sources checked 2026-11-15 · Original unavailable
  2. 아미코젠, 국가 전략 연구소에 '차세대 바이오 소재' 전격 투입 ↗뉴스핌 · Published 2026-02-27 · Sources checked 2026-11-15 · Original unavailable